Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Conjupri
Synonyms :
levamlodipine
Class :
Calcium channel blockers and antihypertensives
Dosage Forms & Strengths
Tablet, Oral:
2.5 mg
5 mg
1.25 - 2.5
mg
Orally 
once a day
every 1 to 2 weeks (Not more than 5mg/day)
1.25 to 2.5 mg orally once a day every 1 to 2 weeks (Not more than 5mg/day)
Dosage Forms & Strengths
Tablet, Oral:
2.5 mg
5 mg
Children and Adolescents 6 to <17 years:
1.25 - 2.5
mg
Orally 
once a day
every 1 to 2 weeks (Not more than 5mg/day)
Children and Adolescents 6 to <17 years: 1.25 to 2.5 mg orally once a day every 1 to 2 weeks (Not more than 5mg/day
may increase the hypotensive effect of alpha1-blockers
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when it is combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may enhance the serum concentration of each other when combined
may have an increased hyperkalemic effect when combined with spironolactone
may have an increased hyperkalemic effect when combined with spironolactone
may have an increased hyperkalemic effect when combined with spironolactone
may have an increased hyperkalemic effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
bunazosin (Not available in the United States)
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
May enhance the hyperkalemic effect when combined with Calcium Channel Blockers
may enhance the hypotensive effect of calcium channel blockers
bunazosin (Not available in the United States)
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the hypotensive effect of calcium channel blockers
may enhance the AV-blocking effect of cardiac glycosides
may enhance the AV-blocking effect of cardiac glycosides
may enhance the AV-blocking effect of cardiac glycosides
may enhance the AV-blocking effect of cardiac glycosides
may enhance the AV-blocking effect of cardiac glycosides
may enhance the AV-blocking effect of cardiac glycosides
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the hypotensive effect of alpha1-blockers
bunazosin (Not available in the United States)
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may decrease the therapeutic effect of calcium salts
may decrease the therapeutic effect of calcium salts
may decrease the therapeutic effect of calcium salts
may decrease the therapeutic effect of calcium salts
may decrease the therapeutic effect of calcium salts
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
bunazosin (Not available in the United States)
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
may increase the hypotensive effect of alpha1-blockers
levamlodipine: it may enhance the serum concentration of simvastatin
calcium salts reduce the efficacy of calcium channel blockers
calcium salts reduce the efficacy of calcium channel blockers
calcium salts reduce the efficacy of calcium channel blockers
calcium salts reduce the efficacy of calcium channel blockers
calcium salts reduce the efficacy of calcium channel blockers
may enhance the serum concentration of CYP3A4 inhibitors
may increase the antiplatelet effect of antiplatelet agents
may have an increased adverse effect when combined with atosiban
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may enhance the serum concentration when combined with calcium channel blockers
may decrease the therapeutic effect when combined with clopidogrel
may enhance the serum concentration when combined with cyclosporine
may have an increased orthostatic hypotensive effect when combined with calcium channel blockers
may increase the hypotensive effect of Inhalational Anaesthetics
may enhance the serum concentration of CYP3A4 Inhibitors
may enhance the serum concentration of cyclosporine
may have an increasingly adverse effect when combined with atosiban
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
it increases the toxicity of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
they decrease the efficacy of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
inhalational anesthetics increase the effect of hypotension of calcium channel blockers
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
It may enhance the risk of adverse effects when combined with antianginal drugs
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
bunazosin (Not available in the United States)
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may have an increased hypotensive effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
may decrease the therapeutic effect when combined with calcium channel blockers
Frequency defined:
>10%
Atrial fibrillation
Nausea
1% to 10%
Vomiting
Headache
Kidney injury
<1% Postmarketing
Myocardial infarction
Syncope
Dyspnea
Pregnancy consideration: Levamlodipine can be excreted in the female placenta.
Lactation: Levamlodipine can be excreted in breast milk.
Â
Pregnancy category:
Patient information leaflet
Generic Name: Levamlodipine
Pronounced: levamlodipine
Why do we use levamlodipine?
Levamlodipine is used for the treatment of hypertension and may be prescribed for other reasons by a doctor.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
